The record

LegislationLegislation· Dec 2024
HR 7188

Sponsored by John R. Moolenaar (R)

Shandra Eisenga Human Cell and Tissue Product Safety Act

Would have updated federal rules on human cell and tissue donations and set new fines for violations.

Tradeoff

Would have set civil fines of $20,000 per violation, with no more than $10 million in fines per proceeding. Would also have required the Food and Drug Administration (FDA) to update donor safety guidance on tuberculosis and sepsis risks.

What's in it

See official bill text

The House passed this bill by on December 16, 2024. The Senate never voted on it before the Congress ended, so the bill expired.

  1. House

    Introduced

    (Feb 1, 2024)

  2. House

    Committee on Energy and Commerce(Feb 1, 2024)

  3. House

    The Committee on Energy and Commerce voted to send it to the floor

    Reported 40 - 0(Sep 18, 2024)

    Committee report H. Rept. 118-766.

  4. House

    Passage of the bill

    Passed by (Dec 16, 2024)

    No individual votes were recorded.

  5. Senate

    Received from the House

    Received(Dec 17, 2024)